nodes	percent_of_prediction	percent_of_DWPC	metapath
Clenbuterol—ADRB1—dilated cardiomyopathy	0.304	0.358	CbGaD
Clenbuterol—TNF—dilated cardiomyopathy	0.288	0.34	CbGaD
Clenbuterol—ADRB2—dilated cardiomyopathy	0.255	0.301	CbGaD
Clenbuterol—NGF—sympathetic nervous system—dilated cardiomyopathy	0.0343	0.716	CbGeAlD
Clenbuterol—NGF—heart—dilated cardiomyopathy	0.00482	0.101	CbGeAlD
Clenbuterol—ADRB1—cardiac ventricle—dilated cardiomyopathy	0.00191	0.0399	CbGeAlD
Clenbuterol—ADRB1—myocardium—dilated cardiomyopathy	0.0018	0.0375	CbGeAlD
Clenbuterol—Bambuterol—ADRB2—dilated cardiomyopathy	0.00141	0.187	CrCbGaD
Clenbuterol—Pirbuterol—ADRB1—dilated cardiomyopathy	0.00127	0.168	CrCbGaD
Clenbuterol—ADRB1—heart—dilated cardiomyopathy	0.00125	0.0262	CbGeAlD
Clenbuterol—CYP1A1—cardiac ventricle—dilated cardiomyopathy	0.00123	0.0257	CbGeAlD
Clenbuterol—ADRB1—cardiac atrium—dilated cardiomyopathy	0.00107	0.0224	CbGeAlD
Clenbuterol—Pirbuterol—ADRB2—dilated cardiomyopathy	0.00107	0.142	CrCbGaD
Clenbuterol—Terbutaline—ADRB2—dilated cardiomyopathy	0.000871	0.115	CrCbGaD
Clenbuterol—Bupranolol—ADRB1—dilated cardiomyopathy	0.000819	0.109	CrCbGaD
Clenbuterol—CYP1A1—heart—dilated cardiomyopathy	0.000809	0.0169	CbGeAlD
Clenbuterol—Salbutamol—ADRB1—dilated cardiomyopathy	0.00077	0.102	CrCbGaD
Clenbuterol—CYP1A1—cardiac atrium—dilated cardiomyopathy	0.000692	0.0144	CbGeAlD
Clenbuterol—Bupranolol—ADRB2—dilated cardiomyopathy	0.000688	0.0913	CrCbGaD
Clenbuterol—Salbutamol—ADRB2—dilated cardiomyopathy	0.000647	0.0858	CrCbGaD
Clenbuterol—NGF—PI3K/AKT activation—EGFR—dilated cardiomyopathy	0.00024	0.00248	CbGpPWpGaD
Clenbuterol—TNF—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	0.000239	0.00247	CbGpPWpGaD
Clenbuterol—TNF—Allograft Rejection—FAS—dilated cardiomyopathy	0.000239	0.00246	CbGpPWpGaD
Clenbuterol—TNF—Alzheimers Disease—FAS—dilated cardiomyopathy	0.000239	0.00246	CbGpPWpGaD
Clenbuterol—TNF—Apoptosis—LMNA—dilated cardiomyopathy	0.000239	0.00246	CbGpPWpGaD
Clenbuterol—TNF—Apoptosis—FASLG—dilated cardiomyopathy	0.000236	0.00243	CbGpPWpGaD
Clenbuterol—TNF—Selenium Micronutrient Network—GPX1—dilated cardiomyopathy	0.000234	0.00241	CbGpPWpGaD
Clenbuterol—NGF—MAPK Signaling Pathway—RAF1—dilated cardiomyopathy	0.000233	0.0024	CbGpPWpGaD
Clenbuterol—TNF—Ceramide signaling pathway—RAF1—dilated cardiomyopathy	0.000231	0.00238	CbGpPWpGaD
Clenbuterol—NGF—Signaling by NGF—RAC1—dilated cardiomyopathy	0.00023	0.00237	CbGpPWpGaD
Clenbuterol—ADRB3—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.000228	0.00235	CbGpPWpGaD
Clenbuterol—TNF—Apoptosis—FAS—dilated cardiomyopathy	0.000227	0.00234	CbGpPWpGaD
Clenbuterol—TNF—MicroRNAs in cardiomyocyte hypertrophy—RAC1—dilated cardiomyopathy	0.000223	0.0023	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—GJA1—dilated cardiomyopathy	0.000223	0.0023	CbGpPWpGaD
Clenbuterol—ADRB2—G alpha (s) signalling events—ADRB1—dilated cardiomyopathy	0.000214	0.00221	CbGpPWpGaD
Clenbuterol—TNF—MicroRNAs in cardiomyocyte hypertrophy—AGT—dilated cardiomyopathy	0.000213	0.00219	CbGpPWpGaD
Clenbuterol—ADRB3—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.000212	0.00218	CbGpPWpGaD
Clenbuterol—CYP1A1—Aryl Hydrocarbon Receptor—CD36—dilated cardiomyopathy	0.00021	0.00217	CbGpPWpGaD
Clenbuterol—TNF—Cardiac Hypertrophic Response—RAF1—dilated cardiomyopathy	0.000208	0.00214	CbGpPWpGaD
Clenbuterol—TNF—TNF alpha Signaling Pathway—RAC1—dilated cardiomyopathy	0.000207	0.00214	CbGpPWpGaD
Clenbuterol—ADRB3—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.000205	0.00211	CbGpPWpGaD
Clenbuterol—CYP1A1—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000202	0.00208	CbGpPWpGaD
Clenbuterol—NGF—NGF signalling via TRKA from the plasma membrane—RAF1—dilated cardiomyopathy	0.000198	0.00204	CbGpPWpGaD
Clenbuterol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000195	0.00201	CbGpPWpGaD
Clenbuterol—ADRB3—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000195	0.00201	CbGpPWpGaD
Clenbuterol—TNF—Toll-like Receptor Signaling Pathway—RAC1—dilated cardiomyopathy	0.000191	0.00197	CbGpPWpGaD
Clenbuterol—ADRB2—Calcium Regulation in the Cardiac Cell—ADRB1—dilated cardiomyopathy	0.000185	0.0019	CbGpPWpGaD
Clenbuterol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000182	0.00187	CbGpPWpGaD
Clenbuterol—TNF—Downstream signaling in naïve CD8+ T cells—RAF1—dilated cardiomyopathy	0.000179	0.00185	CbGpPWpGaD
Clenbuterol—TNF—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.000178	0.00184	CbGpPWpGaD
Clenbuterol—ADRB1—G alpha (s) signalling events—ADRB2—dilated cardiomyopathy	0.000177	0.00183	CbGpPWpGaD
Clenbuterol—ADRB3—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000176	0.00181	CbGpPWpGaD
Clenbuterol—ADRB3—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000175	0.00181	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—RAC1—dilated cardiomyopathy	0.00017	0.00175	CbGpPWpGaD
Clenbuterol—ADRB2—Arf6 signaling events—EGFR—dilated cardiomyopathy	0.000169	0.00174	CbGpPWpGaD
Clenbuterol—ADRB3—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000166	0.00171	CbGpPWpGaD
Clenbuterol—TNF—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	0.000164	0.00169	CbGpPWpGaD
Clenbuterol—TNF—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	0.000164	0.00169	CbGpPWpGaD
Clenbuterol—NGF—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.000162	0.00166	CbGpPWpGaD
Clenbuterol—TNF—Adipogenesis—FAS—dilated cardiomyopathy	0.00016	0.00165	CbGpPWpGaD
Clenbuterol—NGF—MAPK Signaling Pathway—EGFR—dilated cardiomyopathy	0.00016	0.00165	CbGpPWpGaD
Clenbuterol—ADRB1—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	0.000156	0.00161	CbGpPWpGaD
Clenbuterol—TNF—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.000155	0.00159	CbGpPWpGaD
Clenbuterol—ADRB1—Calcium Regulation in the Cardiac Cell—ADRB2—dilated cardiomyopathy	0.000153	0.00158	CbGpPWpGaD
Clenbuterol—ADRB2—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	0.000153	0.00157	CbGpPWpGaD
Clenbuterol—NGF—Signaling by NGF—RAF1—dilated cardiomyopathy	0.000152	0.00157	CbGpPWpGaD
Clenbuterol—NGF—MAPK Signaling Pathway—TNF—dilated cardiomyopathy	0.000152	0.00157	CbGpPWpGaD
Clenbuterol—TNF—Adipogenesis—AGT—dilated cardiomyopathy	0.00015	0.00155	CbGpPWpGaD
Clenbuterol—ADRB3—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00015	0.00155	CbGpPWpGaD
Clenbuterol—TNF—Regulation of toll-like receptor signaling pathway—RAC1—dilated cardiomyopathy	0.000149	0.00154	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000149	0.00153	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000149	0.00153	CbGpPWpGaD
Clenbuterol—TNF—MicroRNAs in cardiomyocyte hypertrophy—RAF1—dilated cardiomyopathy	0.000148	0.00152	CbGpPWpGaD
Clenbuterol—TNF—Apoptosis—FASLG—dilated cardiomyopathy	0.000145	0.00149	CbGpPWpGaD
Clenbuterol—ADRB3—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000142	0.00147	CbGpPWpGaD
Clenbuterol—TNF—Apoptosis—FAS—dilated cardiomyopathy	0.000139	0.00144	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000138	0.00142	CbGpPWpGaD
Clenbuterol—TNF—TNF alpha Signaling Pathway—RAF1—dilated cardiomyopathy	0.000137	0.00142	CbGpPWpGaD
Clenbuterol—NGF—NGF signalling via TRKA from the plasma membrane—EGFR—dilated cardiomyopathy	0.000136	0.0014	CbGpPWpGaD
Clenbuterol—TNF—MAPK Signaling Pathway—FASLG—dilated cardiomyopathy	0.000135	0.0014	CbGpPWpGaD
Clenbuterol—ADRB1—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.000135	0.00139	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor—CD36—dilated cardiomyopathy	0.000134	0.00138	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000134	0.00138	CbGpPWpGaD
Clenbuterol—ADRB2—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.000132	0.00136	CbGpPWpGaD
Clenbuterol—CYP1A1—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	0.000131	0.00135	CbGpPWpGaD
Clenbuterol—TNF—MAPK Signaling Pathway—FAS—dilated cardiomyopathy	0.000131	0.00135	CbGpPWpGaD
Clenbuterol—CYP1A2—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000129	0.00133	CbGpPWpGaD
Clenbuterol—TNF—MAPK Signaling Pathway—RAC1—dilated cardiomyopathy	0.000128	0.00132	CbGpPWpGaD
Clenbuterol—ADRB1—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.000126	0.0013	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000125	0.00129	CbGpPWpGaD
Clenbuterol—ADRB2—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.000123	0.00127	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	0.000122	0.00126	CbGpPWpGaD
Clenbuterol—ADRB2—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.000119	0.00123	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	0.000118	0.00121	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000118	0.00121	CbGpPWpGaD
Clenbuterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000116	0.00119	CbGpPWpGaD
Clenbuterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000116	0.00119	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	0.000116	0.00119	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000114	0.00118	CbGpPWpGaD
Clenbuterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000113	0.00117	CbGpPWpGaD
Clenbuterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000113	0.00117	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000109	0.00112	CbGpPWpGaD
Clenbuterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000108	0.00111	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—PSEN2—dilated cardiomyopathy	0.000107	0.00111	CbGpPWpGaD
Clenbuterol—ADRB3—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000106	0.00109	CbGpPWpGaD
Clenbuterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000105	0.00109	CbGpPWpGaD
Clenbuterol—CYP1A1—PPARA activates gene expression—CD36—dilated cardiomyopathy	0.000105	0.00108	CbGpPWpGaD
Clenbuterol—NGF—Signaling by NGF—EGFR—dilated cardiomyopathy	0.000105	0.00108	CbGpPWpGaD
Clenbuterol—ADRB1—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000104	0.00107	CbGpPWpGaD
Clenbuterol—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CD36—dilated cardiomyopathy	0.000102	0.00106	CbGpPWpGaD
Clenbuterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000102	0.00105	CbGpPWpGaD
Clenbuterol—ADRB2—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000102	0.00105	CbGpPWpGaD
Clenbuterol—ADRB1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	9.87e-05	0.00102	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—PSEN2—dilated cardiomyopathy	9.82e-05	0.00101	CbGpPWpGaD
Clenbuterol—CYP1A1—PPARA activates gene expression—AGT—dilated cardiomyopathy	9.43e-05	0.000971	CbGpPWpGaD
Clenbuterol—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—AGT—dilated cardiomyopathy	9.23e-05	0.00095	CbGpPWpGaD
Clenbuterol—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	9.01e-05	0.000928	CbGpPWpGaD
Clenbuterol—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	9.01e-05	0.000928	CbGpPWpGaD
Clenbuterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	8.92e-05	0.000918	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	8.83e-05	0.000909	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	8.83e-05	0.000909	CbGpPWpGaD
Clenbuterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	8.72e-05	0.000898	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—AGTR2—dilated cardiomyopathy	8.72e-05	0.000898	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—CXCL2—dilated cardiomyopathy	8.72e-05	0.000898	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR ligand binding—CXCL2—dilated cardiomyopathy	8.64e-05	0.00089	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR ligand binding—AGTR2—dilated cardiomyopathy	8.64e-05	0.00089	CbGpPWpGaD
Clenbuterol—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	8.58e-05	0.000884	CbGpPWpGaD
Clenbuterol—CYP1A1—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	8.58e-05	0.000884	CbGpPWpGaD
Clenbuterol—TNF—MAPK Signaling Pathway—RAF1—dilated cardiomyopathy	8.49e-05	0.000875	CbGpPWpGaD
Clenbuterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	8.46e-05	0.000871	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	8.41e-05	0.000866	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	8.41e-05	0.000866	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	8.38e-05	0.000863	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	8.21e-05	0.000845	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—CXCR3—dilated cardiomyopathy	8.1e-05	0.000835	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR ligand binding—AGT—dilated cardiomyopathy	8.05e-05	0.000829	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR ligand binding—CXCR3—dilated cardiomyopathy	8.03e-05	0.000827	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	7.97e-05	0.000821	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—ADRB1—dilated cardiomyopathy	7.85e-05	0.000808	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	7.81e-05	0.000805	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR ligand binding—ADRB1—dilated cardiomyopathy	7.78e-05	0.000801	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—EGFR—dilated cardiomyopathy	7.73e-05	0.000796	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	7.66e-05	0.000789	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—AGTR2—dilated cardiomyopathy	7.63e-05	0.000786	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—CXCL2—dilated cardiomyopathy	7.63e-05	0.000786	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	7.57e-05	0.00078	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	7.49e-05	0.000772	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—CXCR3—dilated cardiomyopathy	7.1e-05	0.000731	CbGpPWpGaD
Clenbuterol—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—dilated cardiomyopathy	7.06e-05	0.000727	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—ADRB1—dilated cardiomyopathy	6.87e-05	0.000708	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	6.79e-05	0.000699	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—ITGB1—dilated cardiomyopathy	6.72e-05	0.000693	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—AGTR1—dilated cardiomyopathy	6.7e-05	0.00069	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR ligand binding—AGTR1—dilated cardiomyopathy	6.64e-05	0.000684	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	6.46e-05	0.000666	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	6.44e-05	0.000663	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—ADRB2—dilated cardiomyopathy	6.36e-05	0.000655	CbGpPWpGaD
Clenbuterol—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—dilated cardiomyopathy	6.36e-05	0.000655	CbGpPWpGaD
Clenbuterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	6.27e-05	0.000646	CbGpPWpGaD
Clenbuterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	6.14e-05	0.000632	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	6.13e-05	0.000632	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—AGTR1—dilated cardiomyopathy	5.87e-05	0.000605	CbGpPWpGaD
Clenbuterol—TNF—MAPK Signaling Pathway—EGFR—dilated cardiomyopathy	5.82e-05	0.0006	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	5.75e-05	0.000592	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	5.75e-05	0.000592	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—CD36—dilated cardiomyopathy	5.74e-05	0.000591	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—ADRB2—dilated cardiomyopathy	5.57e-05	0.000574	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—ANKRD1—dilated cardiomyopathy	5.57e-05	0.000573	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	5.47e-05	0.000564	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	5.47e-05	0.000564	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	5.46e-05	0.000563	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—RAC1—dilated cardiomyopathy	5.4e-05	0.000557	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	5.26e-05	0.000541	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—TAZ—dilated cardiomyopathy	5.23e-05	0.000539	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—PSEN2—dilated cardiomyopathy	5.08e-05	0.000523	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	4.99e-05	0.000514	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	4.99e-05	0.000514	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—RAC1—dilated cardiomyopathy	4.94e-05	0.000508	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	4.88e-05	0.000503	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	4.88e-05	0.000503	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR ligand binding—AGT—dilated cardiomyopathy	4.78e-05	0.000492	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—RAC1—dilated cardiomyopathy	4.76e-05	0.00049	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—SDHA—dilated cardiomyopathy	4.73e-05	0.000487	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—AGT—dilated cardiomyopathy	4.72e-05	0.000486	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR ligand binding—AGT—dilated cardiomyopathy	4.67e-05	0.000481	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	4.64e-05	0.000478	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—AGT—dilated cardiomyopathy	4.55e-05	0.000469	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	4.54e-05	0.000467	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	4.53e-05	0.000467	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	4.53e-05	0.000467	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CXCL2—dilated cardiomyopathy	4.51e-05	0.000464	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—AGTR2—dilated cardiomyopathy	4.51e-05	0.000464	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—CXCL2—dilated cardiomyopathy	4.43e-05	0.000457	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—AGTR2—dilated cardiomyopathy	4.43e-05	0.000457	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	4.39e-05	0.000453	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—RAC1—dilated cardiomyopathy	4.32e-05	0.000445	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	4.21e-05	0.000434	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CXCR3—dilated cardiomyopathy	4.19e-05	0.000432	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—AGT—dilated cardiomyopathy	4.13e-05	0.000425	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—CXCR3—dilated cardiomyopathy	4.12e-05	0.000424	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—ADRB1—dilated cardiomyopathy	4.06e-05	0.000418	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—ADRB1—dilated cardiomyopathy	3.99e-05	0.000411	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	3.84e-05	0.000395	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	3.75e-05	0.000387	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	3.64e-05	0.000375	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—RAF1—dilated cardiomyopathy	3.58e-05	0.000369	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—ANKRD1—dilated cardiomyopathy	3.55e-05	0.000366	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	3.48e-05	0.000359	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—AGTR1—dilated cardiomyopathy	3.47e-05	0.000357	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	3.41e-05	0.000351	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—TAZ—dilated cardiomyopathy	3.34e-05	0.000344	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	3.31e-05	0.00034	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—ADRB2—dilated cardiomyopathy	3.29e-05	0.000339	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—RAF1—dilated cardiomyopathy	3.27e-05	0.000337	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—SDHA—dilated cardiomyopathy	3.02e-05	0.000311	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—PSEN2—dilated cardiomyopathy	3.01e-05	0.00031	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—PSEN2—dilated cardiomyopathy	2.95e-05	0.000304	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	2.89e-05	0.000297	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—RAF1—dilated cardiomyopathy	2.87e-05	0.000295	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.83e-05	0.000291	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	2.83e-05	0.000291	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	2.81e-05	0.00029	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	2.76e-05	0.000285	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—AGT—dilated cardiomyopathy	2.7e-05	0.000278	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CXCL2—dilated cardiomyopathy	2.68e-05	0.000276	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—AGTR2—dilated cardiomyopathy	2.68e-05	0.000276	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—AGT—dilated cardiomyopathy	2.64e-05	0.000272	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—AGTR2—dilated cardiomyopathy	2.62e-05	0.00027	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CXCL2—dilated cardiomyopathy	2.62e-05	0.00027	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—RAC1—dilated cardiomyopathy	2.57e-05	0.000264	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—RAC1—dilated cardiomyopathy	2.55e-05	0.000263	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	2.53e-05	0.000261	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—RAC1—dilated cardiomyopathy	2.51e-05	0.000259	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CXCR3—dilated cardiomyopathy	2.49e-05	0.000256	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—EGFR—dilated cardiomyopathy	2.46e-05	0.000253	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—AGT—dilated cardiomyopathy	2.45e-05	0.000253	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—AGT—dilated cardiomyopathy	2.44e-05	0.000251	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CXCR3—dilated cardiomyopathy	2.43e-05	0.000251	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—AGT—dilated cardiomyopathy	2.4e-05	0.000247	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—ADRB1—dilated cardiomyopathy	2.36e-05	0.000243	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—EGFR—dilated cardiomyopathy	2.24e-05	0.000231	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—AGTR1—dilated cardiomyopathy	2.06e-05	0.000212	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—AGTR1—dilated cardiomyopathy	2.01e-05	0.000207	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.97e-05	0.000202	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.95e-05	0.000201	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.84e-05	0.00019	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.79e-05	0.000185	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.7e-05	0.000175	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—RAF1—dilated cardiomyopathy	1.69e-05	0.000174	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.68e-05	0.000173	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.66e-05	0.000171	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.64e-05	0.000169	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.61e-05	0.000166	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—RAC1—dilated cardiomyopathy	1.52e-05	0.000156	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—RAC1—dilated cardiomyopathy	1.48e-05	0.000153	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—AGT—dilated cardiomyopathy	1.45e-05	0.000149	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—AGT—dilated cardiomyopathy	1.42e-05	0.000146	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—GPX1—dilated cardiomyopathy	1.29e-05	0.000132	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—CD36—dilated cardiomyopathy	1.25e-05	0.000129	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.17e-05	0.00012	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—EGFR—dilated cardiomyopathy	1.16e-05	0.00012	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.14e-05	0.000118	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—AGT—dilated cardiomyopathy	1.13e-05	0.000116	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—RAF1—dilated cardiomyopathy	1.01e-05	0.000104	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—RAF1—dilated cardiomyopathy	9.83e-06	0.000101	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—GPX1—dilated cardiomyopathy	8.2e-06	8.44e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—CD36—dilated cardiomyopathy	7.98e-06	8.22e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—AGT—dilated cardiomyopathy	7.19e-06	7.4e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—EGFR—dilated cardiomyopathy	6.89e-06	7.1e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—EGFR—dilated cardiomyopathy	6.74e-06	6.94e-05	CbGpPWpGaD
